4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-22-002103
Chief Executive Officer acquired 1,737 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2022-01-28 | Option exercise | +938 | $106.59 | $99,981 | 197,539 | D |
| Kummeth Charles R. Chief Executive Officer | 2022-01-28 | Option exercise | +799 | $125.05 | $99,915 | 198,338 | D |
| Derivatives | |||||||
| Kummeth Charles R. Chief Executive Officer | 2022-01-28 | Option exercise · Stock Options (Right to Buy) | −938 | 256,010 | D | ||
| Kummeth Charles R. Chief Executive Officer | 2022-01-28 | Option exercise · Stock Options (Right to Buy) | −799 | 194,771 | D | ||
Loading xslF345X03/rdgdoc.xml…